Priority Date: 11.07.12 (GB 20120012334)

THERAPEUTIC TARGETS FOR ALZHEIMER'S DISEASE

  • Application ID: EP13740046
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
no operation time available
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 142 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 11.07.2012 - Priority Date (GB 20120012334)
  • 16.01.2014 - Publication A2 (WO2014009733)
  • 20.05.2015 - Publication A2 (EP2872529)

IPC Classification